Trial intelligence / Profile preview

Clindamycin Phosphate and Benzoyl Peroxide Combination Gel for Perimenstrual Acne

NCT03122457Phase 2Completed

Sponsor
Icahn School of Medicine at Mount Sinai
Start
Jan 2017
Primary completion
Jul 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of clindamycin and benzoyl peroxide in acne vulgaris, sponsored by Icahn School of Medicine at Mount Sinai. Primary endpoint: Physician Global Assessment at Day 99. Started Jan 2017; status: completed.

02

Drugs

clindamycinbenzoyl peroxide
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on NCT03122457.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03122457.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call